Derivative Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The location and fair values of derivative instruments designated as hedging instruments in the Condensed Consolidated Balance Sheets as of March 31, 2020, are shown in the following table:

	As of
	March 31,			December 31,
	2020			2019
Interest rate swaps reported in Other current assets	$	—		$	82
Interest rate swaps reported in Accrued liabilities	$	(523	)	$	—
Interest rate swaps reported in Other long-term obligations	$	(1,840	)	$	(78	)
Foreign currency hedges reported in Other current assets	$	—		$	580
Foreign currency hedges reported in Accrued liabilities	$	(2,733	)	$	—

Derivative Instruments, Gain (Loss)

The effect of derivative instruments on the Condensed Consolidated Statements of Earnings is as follows:

	Three Months Ended
	March 31,			March 31,
	2020			2019
Foreign Exchange Contracts:
Amounts reclassified from AOCI to earnings:
Cost of goods sold	$	248		$	42
Selling, general and administrative expense	(5		)	17
Total gain reclassified from AOCI to earnings	243			59
Loss recognized in other expense for hedge ineffectiveness	—			—
Total derivative gain on foreign exchange contracts recognized in earnings	$	243		$	59
Interest Rate Swaps:
Benefit recorded in Interest expense	$	38		$	156
Total gains on derivatives	$	281		$	215